United States Department of Health and Human Services. (2018). The prescription drug & heroin overdose epidemic. https://www.hhs.gov/opioids/ (Last accessed January30, 2019.
2.
ChouR., TurnerJ.A., DevineE.B., HansenR.N., SullivanS.D., BlazinaI., DanaT., BougatsosC., and DeyoR.A. (2015). The effectiveness and risks of long-term opioid therapy for chronic pain: a systematic review for a National Institutes Of Health Pathways To Prevention Workshop. Ann. Intern. Med. 162, 276–286.
3.
BohnertA.S.B., and IlgenM.A. (2019). Understanding links among opioid use, overdose, and suicide. N. Engl. J. Med. 380, 71–79.
4.
White House Council of Economic Advisers. (2017). The Underestimated Cost of the Opioid Crisis. The White House: Washington, DC.
5.
ComptonW.M., JonesC.M., and BaldwinG.T. (2016). Relationship between nonmedical prescription-opioid use and heroin use. N. Engl. J. Med. 374, 154–163.
6.
StumboS.P., YarboroughB.J., McCartyD., WeisnerC., and GreenC.A. (2017). Patient-reported pathways to opioid use disorders and pain-related barriers to treatment engagement. J. Subst. Abuse Treat. 73, 47–54.
7.
TillyJ., SkowronskiS., and RuizS. (2017). The Opioid Public Health Emergency nd Older Adults. Administration for Community Living: Washington, DC.
8.
WeissR.D., PotterJ.S., GriffinM.L., ProvostS.E., FitzmauriceG.M., McDermottK.A., SrisarajivakulE.N., DoddD.R., DreifussJ.A., McHughR.K., and CarrollK.M. (2015). Long-term outcomes from the National Drug Abuse Treatment Clinical Trials Network Prescription Opioid Addiction Treatment Study. Drug Alcohol Depend. 150, 112–119.
9.
CiceroT.J., EllisM.S., SurrattH.L., and KurtzS.P. (2014). The changing face of heroin use in the united states: a retrospective analysis of the past 50 years. JAMA Psychiatry, 71, 821–826.
10.
Topolovec-VranicJ., EnnisN., ColantonioA., CusimanoM.D., HwangS.W., KontosP., OuchterlonyD., and StergiopoulosV. (2012). Traumatic brain injury among people who are homeless: a systematic review. BMC Public Health, 12, 1059.
11.
TurkstraL., JonesD., and TolerH.L. (2003). Brain injury and violent crime. Brain Inj. 17, 39.
12.
BanksM.E. (2007). Overlooked but critical: traumatic brain injury as a consequence of interpersonal violence. Trauma Violence Abuse, 8, 290–298.
13.
SacksA.L., FenskeC.L., GordonW.A., HibbardM.R., PerezK., BrandauS., CantorJ.B., AshmanT.A., and SpielmanL. (2009). Co-morbidity of substance abuse and traumatic brain injury. J. Dual Diagn. 5, 404–417.
14.
Dams-O'ConnorK., CantorJ.B., BrownM., DijkersM.P., SpielmanL.A., and GordonW.A. (2014). Screening for traumatic brain injury: findings and public health implications. J. Head Trauma Rehabil. 29, 479–489.
15.
Harrison-FelixC., PretzC., HammondF.M., CuthbertJ.P., BellJ., CorriganJ., MillerA.C., and Haarbauer-KrupaJ. (2015). Life expectancy after inpatient rehabilitation for traumatic brain injury in the united states. J. Neurotrauma, 32, 1893–1901.
16.
CorriganJ.D., and AdamsR.S. (2019). The intersection of lifetime history of traumatic brain injury and the opioid epidemic. Addict. Behav. 90, 143–145.
17.
CifuD.X., TaylorB.C., CarneW.F., BidelspachD., SayerN.A., ScholtenJ., and CampbellE.H. (2013). Traumatic brain injury, posttraumatic stress disorder, and pain diagnoses in OIF/OEF/OND veterans. J. Rehabil. Res. Dev. 50, 1169–1176.
18.
NampiaparampilD.E. (2008). Prevalence of chronic pain after traumatic brain injury: a systematic review. JAMA, 300, 711–719.
19.
ShermanK.B., GoldbergM., and BellK.R. (2006). Traumatic brain injury and pain. Phys. Med. Rehabil. Clin. N. Am. 17, 473–490.
20.
Beaulieu-BonneauS., St-OngeF., BlackburnM.C., BanvilleA., Paradis-GirouxA.A., and OuelletM.C. (2018). Alcohol and drug use before and during the first year after traumatic brain injury. J. Head Trauma Rehabil. 33, E51–E60.
21.
BombardierC.H., TemkinN.R., MachamerJ., and DikmenS.S. (2003). The natural history of drinking and alcohol-related problems after traumatic brain injury. Arch. Phys. Med. Rehabil. 84, 185–191.
22.
HornerM.D., FergusonP.L., SelassieA.W., LabbateL.A., KnieleK., and CorriganJ.D. (2005). Patterns of alcohol use 1 year after traumatic brain injury: a population-based, epidemiological study. J. Int. Neuropsychol. Soc. 11, 322–330.
23.
YlvisakerM., and FeeneyT.J. (1996). Executive functions after traumatic brain injury: Supported cognition and self-advocacy. Semin. Speech Lang. 17, 217–232.
24.
McDonaldB.C., FlashmanL.A., and SaykinA.J. (2002). Executive dysfunction following traumatic brain injury: neural substrates and treatment strategies. NeuroRehabilitation, 17, 333–344.
25.
MakaryM.A., OvertonH.N., and WangP. (2017). Overprescribing is major contributor to opioid crisis. BMJ, 359, j4792.
26.
MordenN.E., MunsonJ.C., CollaC.H., SkinnerJ.S., BynumJ.P., ZhouW., and MearaE. (2014). Prescription opioid use among disabled medicare beneficiaries: intensity, trends, and regional variation. Med. Care, 52, 852–859.
27.
Dams-O'ConnorK., LandauA., HoffmanJ., and St De LoreJ. (2018). Patient perspectives on quality and access to healthcare after brain injury. Brain Inj. 32, 431–441.
28.
WeissR.D., PotterJ.S., GriffinM.L., McHughR.K., HallerD., JacobsP., GardinJ., 2ndFischer, D., and RosenK.D. (2014). Reasons for opioid use among patients with dependence on prescription opioids: the role of chronic pain. J. Subst. Abuse Treat. 47, 140–145.
29.
JensenM.P., MooreM.R., BockowT.B., EhdeD.M., and EngelJ.M. (2011). Psychosocial factors and adjustment to chronic pain in persons with physical disabilities: a systematic review. Arch. Phys. Med. Rehabil. 92, 146–160.
30.
JensenM.K., ThomsenA.B., and HojstedJ. (2006). 10-year follow-up of chronic non-malignant pain patients: opioid use, health related quality of life and health care utilization. Eur. J. Pain, 10, 423–433.
31.
KennedyJ., RollJ.M., SchraudnerT., MurphyS., and McPhersonS. (2014). Prevalence of persistent pain in the U.S. adult population: new data from the 2010 National Health Interview Survey. J. Pain, 15, 979–984.
32.
EhdeD.M., JensenM.P., EngelJ.M., TurnerJ.A., HoffmanA.J., and CardenasD.D. (2003). Chronic pain secondary to disability: a review. Clin. J. Pain, 19, 3–17.
33.
Dams-O'ConnorK., KetchumJ.M., HartT., and Nakase-RichardsonR. (2017). Traumatic brain injury as a chronic condition: overview of findings from the civilian and veteran tbi model systems. Arch. Phys. Med. Rehabil. 98, e4.
34.
MoshourabR.A., SchaferM., and Al-ChaerE.D. (2015). Chronic pain in neurotrauma: implications on spinal cord and traumatic brain injury, Chapter 11, in: Brain Neurotrauma: Molecular, Neuropsychological, and Rehabilitation Aspects. KobeissyF.H. (ed.). CRC Press/Taylor & Francis: Boca Raton, FL.
35.
BrimO.G., RyffC.D., and KesslerR.C. (2004). The MIDUS National Survey: an overview, in: How Healthy Are We?: A National Study Of Well-Being At Midlife. BrimO.G., RyffC.D., and KesslerR.C. (eds.). The University of Chicago Press: Chicago, IL, pps. 1–36.
36.
Kaiser Family Foundation. (2018). Multiple cause of death 1999–2017 on CDC WONDER Online Database. Centers for Disease Conrol and Prevention: Atlanta GA. http://wonder.cdc.gov/mcd-icd10.html (Last accessed January30, 2019).
37.
GomesT., TadrousM., MamdaniM.M., PatersonJ.M., and JuurlinkD.N. (2018). The burden of opioid-related mortality in the United States. JAMA Netw. Open, 1, e180217.
38.
HammondF.M., BarrettR.S., SheaT., SeelR.T., McAlisterT.W., KaelinD., RyserD.K., CorriganJ.D., CullenN., and HornS.D. (2015). Psychotropic medication use during inpatient rehabilitation for traumatic brain injury. Arch. Phys. Med. Rehabil. 96, S256–253 e214.
39.
HongY., GeraciM., TurkM., LoveB., and McDermottS. (2019). Opioid prescription patterns for adults with longstanding disability and inflammatory conditions compared to other users, using a nationally representative sample. Arch. Phys. Med. Rehabil. 100, 86–94.
40.
BakerD.W. (2017). History of the Joint Commission's pain standards: lessons for today's prescription opioid epidemic. JAMA, 317, 1117–1118.
41.
UnsworthD.J., and MathiasJ.L. (2017). Traumatic brain injury and alcohol/substance abuse: a bayesian meta-analysis comparing the outcomes of people with and without a history of abuse. J. Clin. Exp. Neuropsychol. 39, 547–562.
42.
BjorkJ.M., and GrantS.J. (2009). Does traumatic brain injury increase risk for substance abuse?. J. Neurotrauma, 26, 1077–1082.
43.
FannJ.R., BuringtonB., LeonettiA., JaffeK., KatonW.J., and ThompsonR.S. (2004). Psychiatric illness following traumatic brain injury in an adult health maintenance organization population. Arch. Gen. Psychiatry, 61, 53–61.
44.
VickeryC.D., ShererM., NickT.G., Nakase-RichardsonR., CorriganJ.D., HammondF., MacciocchiS., RipleyD.L., and SanderA. (2008). Relationships among premorbid alcohol use, acute intoxication, and early functional status after traumatic brain injury. Arch. Phys. Med. Rehabil. 89, 48–55.
45.
Kolakowsky-HaynerS.A., GourleyE.V., KreutzerJ.S., MarwitzJ.H., MeadeM.A., and CifuD.X. (2002). Post-injury substance abuse among persons with brain injury and persons with spinal cord injury. Brain Inj. 16, 583–592.
46.
HibbardM.R., UysalS., SliwinskiM., and GordonW.A. (1998). Undiagnosed health issues in individuals with traumatic brain injury living in the community. J. Head Trauma Rehabil. 13, 47–57.
47.
SilverJ.M., KramerR., GreenwaldS., and WeissmanM. (2001). The association between head injuries and psychiatric disorders: findings from the New Haven NIMH Epidemiologic Catchment Area Study. Brain Inj. 15, 935–945.
48.
AdamsR., CorriganJ.D., MohrB.A., WilliamsT.V., and LarsonM.J. (2017). Traumatic brain injury and post-deployment binge drinking among male and female army active duty service members returning from Operation Enduring Freedom/Operation Iraqi Freedom. J. Neurotrauma, 34, 1457–1465.
49.
AdamsR.S., LarsonM.J., CorriganJ.D., HorganC.M., and WilliamsT.V. (2012). Frequent binge drinking after combat-acquired traumatic brain injury among active duty military personnel with a past year combat deployment. J. Head Trauma Rehabil. 27, 349–360.
50.
HudsonT.J., PainterJ.T., GresslerL.E., LuL., WilliamsJ.S., BoothB.M., MartinB.C., SullivanM.D., and EdlundM.J. (2018). Factors associated with opioid initiation in OEF/OIF/OND veterans with traumatic brain injury. Pain Med. 19, 774–787.
51.
AdamsR.S., ThomasC.P., RitterG.A., LeeS., SaadounM., WilliamsT.V., and LarsonM.J. (2019). Predictors of postdeployment prescription opioid receipt and long-term prescription opioid utilization among army active duty soldiers. Mil. Med. 184, e101–e109.
52.
AshmanT.A., GordonW.A., CantorJ.B., and HibbardM.R. (2006). Neurobehavioral consequences of traumatic brain injury. Mt. Sinai J. Med. 73, 999–1005.
53.
HibbardM.R., UysalS., KeplerK., BogdanyJ., and SilverJ. (1998). Axis I psychopathology in individuals with traumatic brain injury. J. Head Trauma Rehabil. 13, 24–39.
54.
BombardierC.H., FannJ.R., TemkinN.R., EsselmanP.C., BarberJ., and DikmenS.S. (2010). Rates of major depressive disorder and clinical outcomes following traumatic brain injury. JAMA, 303, 1938–1945.
55.
HartT., FannJ.R., ChervonevaI., JuengstS.B., RosenthalJ.A., KrellmanJ.W., DreerL.E., and KroenkeK. (2016). Prevalence, risk factors, and correlates of anxiety at 1 year after moderate to severe traumatic brain injury. Arch. Phys. Med. Rehabil. 97, 701–707.
56.
TolliverB.K., and AntonR.F. (2015). Assessment and treatment of mood disorders in the context of substance abuse. Dialogues Clin. Neurosci. 17, 181–190.
57.
MotzkinJ.C., Baskin-SommersA., NewmanJ.P., KiehlK.A., and KoenigsM. (2014). Neural correlates of substance abuse: reduced functional connectivity between areas underlying reward and cognitive control. Hum. Brain Mapp. 35, 4282–4292.
58.
WagnerA.K., SokoloskiJ.E., RenD., ChenX., KhanA.S., ZafonteR.D., MichaelA.C., and DixonC.E. (2005). Controlled cortical impact injury affects dopaminergic transmission in the rat striatum. J. Neurochem. 95, 457–465.
59.
WagnerA.K., PostalB.A., DarrahS.D., ChenX., and KhanA.S. (2007). Deficits in novelty exploration after controlled cortical impact. J. Neurotrauma, 24, 1308–1320.
60.
ReynoldsB. (2006). A review of delay-discounting research with humans: relations to drug use and gambling. Behav. Pharmacol. 17, 651–667.
61.
Di ChiaraG., and BassareoV. (2007). Reward system and addiction: what dopamine does and doesn't do. Curr. Opin. Pharmacol. 7, 69–76.
62.
WaldropA.E., BackS.E., VerduinM.L., and BradyK.T. (2007). Triggers for cocaine and alcohol use in the presence and absence of posttraumatic stress disorder. Addict. Behav. 32, 634–639.
63.
KimS.C., ChoudhryN., FranklinJ.M., BykovK., EikermannM., LiiJ., FischerM.A., and BatemanB.T. (2017). Patterns and predictors of persistent opioid use following hip or knee arthroplasty. Osteoarthr. Cartil. 25, 1399–1406.
64.
RoehrsT.A., and RothT. (2015). Sleep disturbance in substance use disorders. Psychiatr. Clin. North Am. 38, 793–803.
65.
MehalickM.L., and GlueckA.C. (2018). Examining the relationship and clinical management between traumatic brain injury and pain in military and civilian populations. Brain Inj. 32, 1307–1314.
66.
KimS., MorteraM., HuX., KrishnanS., HoffeckerL., HerroldA., TerhorstL., KingL., MachtingerJ., ZumstegJ.M., NegmA., and HeynP. (2019). Overview of pharmacological interventions after traumatic brain injuries: impact on selected outcomes. Brain Inj. 33, 442–455.
67.
National Institute on Disability, Independent Living, and Rehabilitation Research (2018). Summary of Responses from a Request for Information: People with Disabilities and Opioid Use Disorder. Administration for Community Living: Washington, DC, pps. 1–12.
68.
GleasonR.M., KirshK.L., PassikS.D., and ChambersJ.F. (2014). Current access to opioids—survey of chronic pain patients. Pract. Pain Manag. 14, 51–54.
69.
KornblauB.L. (2015). Health in all policies: quality of life of chronic pain patients vs regulations to stop opioid abusers. Presented at the 142nd Annual American Public Health Association Annual Meeting and Expo 2015, Chicago.
70.
WestS.L. (2007). The accessibility of substance abuse treatment facilities in the United States for persons with disabilities. J. Subst. Abuse Treat. 33, 1–5.
71.
VolkowN.D., JonesE.B., EinsteinE.B., and WargoE.M. (2018). Prevention and treatment of opioid misuse and addiction: a review. JAMA Psychiatry, 76, 208–216.
72.
KarakusM. (2018). Response to NIDILRR RFI Using Medicaid Data: Prevalence of Opioid Use Disorder and Medication-Assisted Treatment. IBM Watson Health: New York.
73.
GrosD.F., LancasterC.L., HornerM.D., SzafranskiD.D., and BackS.E. (2017). The influence of traumatic brain injury on treatment outcomes of concurrent treatment for ptsd and substance use disorders using prolonged exposure (COPE) in veterans. Compr. Psychiatry, 78, 48–53.
74.
GallagherM., McLeodH.J., and McMillanT.M. (2019). A systematic review of recommended modifications of cbt for people with cognitive impairments following brain injury. Neuropsychol. Rehabil. 29, 1–21.
75.
DaneW. (2018). The solution to opioids is treatment. Brain Injury Association of America: ViennaVA. https://www.biausa.org/public-affairs/media/the-solution-to-opioids-is-treatment (Last accessed January30, 2019).
76.
ChouR., FanciulloG.J., FineP.G., MiaskowskiC., PassikS.D., and PortenoyR.K. (2009). Opioids for chronic noncancer pain: prediction and identification of aberrant drug-related behaviors: a review of the evidence for an American Pain Society And American Academy Of Pain Medicine clinical practice guideline. J. Pain, 10, 131–146.
77.
EdlundM.J., MartinB.C., FanM.Y., DevriesA., BradenJ.B., and SullivanM.D. (2010). Risks for opioid abuse and dependence among recipients of chronic opioid therapy: results from the Troup Study. Drug Alcohol Depend. 112, 90–98.
78.
RiceJ.B., WhiteA.G., BirnbaumH.G., SchillerM., BrownD.A., and RolandC.L. (2012). A model to identify patients at risk for prescription opioid abuse, dependence, and misuse. Pain Med. 13, 1162–1173.
79.
DonovanD.M., KivlahanD.R., KaddenR.M., and HillD. (2001). Cognitive impairment as a patient-treatment matching hypothesis, in: Project Match Hypothesis: Results and Causal Chain Analyses. LongabaughR., WirtzP.W. (eds.). National Institute on Alcohol Abuse and Alcoholism: Rockville, MD, pps. 62–81.
80.
AharonovichE., NunesE., and HasinD. (2003). Cognitive impairment, retention and abstinence among cocaine abusers in cognitive-behavioral treatment. Drug Alcohol Depend. 71, 207–211.
81.
AharonovichE., HasinD.S., BrooksA.C., LiuX., BisagaA., and NunesE.V. (2006). Cognitive deficits predict low treatment retention in cocaine dependent patients. Drug Alcohol Depend. 81, 313–322.
82.
Harrison-FelixC., KetchumJ., HammondF., Dams-O'ConnorK., CorriganJ., MillerC., Haarbauer-KrupaJ., and BellJ. (2016). Mortality secondary to accidental poisoning after inpatient rehabilitation for traumatic brain injury. Presented at the 11th World Congress on Brain Injury, The Hague, The Netherlands.
83.
GrigorakosL., SakagianniK., TsigouE., ApostolakosG., NikolopoulosG., and VeldekisD. (2010). Outcome of acute heroin overdose requiring intensive care unit admission. J. Opioid Manag. 6, 227–231.
84.
National Institute on Drug Abuse (2019). Opioids. https://www.drugabuse.gov/drugs-abuse/opioids (Last accessed January30, 2019).
85.
ImJ.J., ShachterR.D., OlivaE.M., HendersonP.T., PaikM.C., TraftonJ.A., and TeamP. (2015). Association of care practices with suicide attempts in us veterans prescribed opioid medications for chronic pain management. J. Gen. Intern. Med. 30, 979–991.
86.
HassamalS., MiottoK., WangT., and SaxonA.J. (2016). A narrative review: The effects of opioids on sleep disordered breathing in chronic pain patients and methadone maintained patients. Am. J. Addict. 25, 452–465.
87.
CorreaD., FarneyR.J., ChungF., PrasadA., LamD., and WongJ. (2015). Chronic opioid use and central sleep apnea: A review of the prevalence, mechanisms, and perioperative considerations. Anesth. Analg. 120, 1273–1285.
88.
DoneganD., and BancosI. (2018). Opioid-induced adrenal insufficiency. Mayo Clin. Proc. 93, 937–944.
89.
DublinS., WalkerR.L., GrayS.L., HubbardR.A., AndersonM.L., YuO., CraneP.K., and LarsonE.B. (2015). Prescription opioids and risk of dementia or cognitive decline: a prospective cohort study. J. Am. Geriatr. Soc. 63, 1519–1526.
90.
Nakase-RichardsonR., ShererM., BarnettS.D., YablonS.A., EvansC.C., KretzmerT., SchwartzD.J., and ModarresM. (2013). Prospective evaluation of the nature, course, and impact of acute sleep abnormality after traumatic brain injury. Arch. Phys. Med. Rehabil. 94, 875–882.
91.
HammondF.M., CorriganJ.D., KetchumJ.M., MalecJ.F., Dams-O'ConnorK., HartT., NovackT.A., BognerJ., DahdahM.N., and WhiteneckG.G. (2019). Prevalence of medical and psychiatric comorbidities following traumatic brain injury. J. Head Trauma Rehabil. [Epub ahead of print.]
92.
KumarR.G., JuengstS.B., WangZ., Dams-O'ConnorK., DikmenS.S., O'Neil-PirozziT.M., DahdahM.N., HammondF.M., FelixE.R., ArenthP.M., and WagnerA.K. (2018). Epidemiology of comorbid conditions among adults 50 years and older with traumatic brain injury. J. Head Trauma Rehabil. 33, 15–24.
93.
WilsonL., StewartW., Dams-O'ConnorK., Diaz-ArrastiaR., HortonL., MenonD.K., and PolinderS. (2017). The chronic and evolving neurological consequences of traumatic brain injury. Lancet Neurol. 16, 813–825.
94.
Dams-O'ConnorK., GuettaG., Hahn-KetterA.E., and FedorA. (2016). Traumatic brain injury as a risk factor for Alzheimer's disease: current knowledge and future directions. Neurodegener. Dis. Manag. 6, 417–429.
95.
AntonR.F., OrosziG., O'MalleyS., CouperD., SwiftR., PettinatiH., and GoldmanD. (2008). An evaluation of mu-opioid receptor (OPRM1) as a predictor of naltrexone response in the treatment of alcohol dependence: results from the combined pharmacotherapies and behavioral interventions for alcohol dependence (COMBINE) study. Arch. Gen. Psychiatry, 65, 135–144.
96.
MarlattG.A., and DonovanD.M. (2005). Relapse Prevention: Maintenance Strategies in the Treatment of Addictive Behaviors, 2nd ed. Guilford Press: New York.
97.
The Opioid Therapy for Chronic Pain Work Group (2017). VA/DoD Clinical Practice Guideline For Opioid Therapy For Chronic Pain. United States Department of Veteran Affiars: Washington, DC.
98.
SealK.H., BertenthalD., BarnesD.E., ByersA.L., GibsonC.J., RifeT.L., and YaffeK. (2018). Traumatic brain injury and receipt of prescription opioid therapy for chronic pain in Iraq and Afghanistan veterans: do clinical practice guidelines matter?. J. Pain, 19, 931–941.
99.
CorriganJ.D., and ColeT.B. (2008). Substance use disorders and clinical management of traumatic brain injury and posttraumatic stress disorder. JAMA, 300, 720–721.
100.
CorriganJ.D., and MysiwW. (2012). Substance abuse among persons withTBI, in: Brain injury Medicine: Principles and Practice. ZaslerN.D., KatzD.I., ZafonteR.D., ArciniegasD.B., BullockM.R., and KreutzerJ.S. (eds.). Demos Medical Publishing: New York, pps. 1315–1328.
101.
Cordovilla-GuardiaS., Vilar-LopezR., Lardelli-ClaretP., Guerrero-LopezF., and Fernandez-MondejarE. (2017). Alcohol or drug use and trauma recidivism. Nurs. Res. 66, 399–404.
102.
HawthorneG., KayeA.H., GruenR., HousemanD., and BauerI. (2011). Traumatic brain injury and quality of life: initial Australian validation of the QOLIBRI. J. Clin. Neurosci. 18, 197–202.
103.
McIsaacK.E., MoserA., MoineddinR., KeownL.A., WiltonG., StewartL.A., ColantonioA., NathensA.B., and MathesonF.I. (2016). Association between traumatic brain injury and incarceration: a population-based cohort study. CMAJ Open, 4, E746–E753.
104.
ChenQ., LarochelleM.R., WeaverD.T., LietzA.P., MuellerP.P., MercaldoS., WakemanS.E., FreedbergK.A., RaphelT.J., KnudsenA.B., PandharipandeP.V., and ChhatwalJ. (2019). Prevention of prescription opioid misuse and projected overdose deaths in the United States. JAMA Netw. Open, 2, e187621.
105.
LydenJ., and BinswangerI.A. (2019). The United States opioid epidemic. Semin. Perinatol. 43, 123–131.
106.
ReinhartM., ScarpatiL.M., KirsonN.Y., PattonC., ShakN., and ErensenJ.G. (2018). The economic burden of abuse of prescription opioids: a systematic literature review from 2012 to 2017. Appl. Health Econ. Health Policy, 16, 609–632.